Clinical Trials
2 trialsNCT01989572 2020-07-07
Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00000124 2006-06-02
Collaborative Ocular Melanoma Study (COMS)
National Eye Institute (NEI)
Phase 3 Unknown